The stem cell gestalt of Geron's Goodbye and the future of ACT - The Niche
Last year one of the biggest events in the stem cell field was biotech Geron’s punting its embryonic stem cell (ESC) program. Much consternation followed. Some folks opposed to ESCs happily pronounced ESC research dead. Some folks in favor of [...]